Our firm is about people. That is our motto and that will always be our reality.
We do our best to get to know our clients, understand their situations, and get them the compensation they deserve.
At TorHoerman Law, we believe that if we continue to focus on the people that we represent, and continue to be true to the people that we are – justice will always be served.
Without our team, we would’nt be able to provide our clients with anything close to the level of service they receive when they work with us.
The TorHoerman Law Team commits to the sincere belief that those injured by the misconduct of others, especially large corporate profit mongers, deserve justice for their injuries.
Our team is what has made TorHoerman Law a very special place since 2009.
Question: What are the problems with Bard Power Port Devices?
Answer: The Bard PowerPort device has faced concerns due to flaws in its catheter component, particularly from the use of Chronoflex AL and manufacturing defects, leading to potential fractures, migration, and malfunction.
Over time, the catheter’s durability may be compromised due to the degradation of its mechanical properties.
On this page, we’ll discuss this question in further depth, provide an overview of the Bard PowerPort Lawsuits, review potential settlement amounts in the Bard PowerPort Lawsuit, and much more.
The Bard PowerPort is an implantable, power-injectable venous access device used for long-term administration of medications, fluids, or chemotherapy.
Recently, the Bard Power Port device has been linked to serious injuries and complications.
Bard PowerPort Lawsuits claim that materials used on the implanted port catheter devices may make them more susceptible to catheter fracture and catheter migration.
Catheter fracture and catheter migration can lead to severe and persistent pain, serious injuries, and other complications including:
If you or a loved one used a potentially defective Bard PowerPort device and suffered injuries, you may be eligible to file a Bard PowerPort Lawsuit.
Contact TorHoerman Law’s Bard PowerPort Injury Lawyers for a free consultation.
You can also use the chatbot on this page to find out if you qualify to file a Bard PowerPort Lawsuit instantly.
Our Bard PowerPort Lawyers are aware of potential defects and issues with the Bard Power Port catheter devices, and we are here to help victims seek justice.
Reach out to our Bard PowerPort Lawyers today for a free consultation and find out how we can help you.
Thousands of individuals with an implant port system implanted for long-term vascular access have come forward alleging injuries linked to Bard’s vascular access devices.
These cases form the basis of the growing Bard PowerPort catheter lawsuits, which argue that the device’s catheter material and port design created preventable risks that were not adequately disclosed.
As filings increased nationwide, the Judicial Panel on Multidistrict Litigation centralized all federal cases into MDL No. 3081.
The Bard PowerPort MDL was assigned to Judge David Campbell in the U.S. District Court for Arizona..
This structure allows one court to manage shared evidence, coordinate expert evaluations, and resolve pretrial issues efficiently across thousands of pending lawsuits.
The litigation is now advancing through the discovery process, where both sides exchange documents, analyze device testing, depose experts, and inspect explanted PowerPort components.
As of January 2026, there are 2,325 lawsuits pending in the Bard PowerPort multidistrict litigation (MDL).
The first federal bellwether trial in the Bard PowerPort MDL is scheduled for April 21, 2026.
The Bard PowerPort MDL is expected to continue growing, with more cases being filed as awareness of the risks increases.
Plaintiffs describe a wide range of medical complications, including infections, blood clots, catheter fractures, and migration of broken components into major vessels.
Bard PowerPort claims involve complex engineering, medical, and regulatory questions, making the centralized MDL essential for consistent oversight.

Bard PowerPort lawsuit allegations include:
As the MDL progresses, Bard PowerPort trials will help evaluate how juries respond to the evidence presented and may influence future settlement discussions.
Although no global resolution has been reached, the ongoing litigation continues to shape the legal and medical understanding of the injuries associated with Bard’s port systems.
The lawsuits involve multiple models of the Bard implanted port catheter, all designed to deliver long-term vascular access for patients who require repeated infusions.
These devices are widely used among cancer patients undergoing chemotherapy, making reliability and structural integrity essential for safe treatment.
Plaintiffs allege that defects in the catheter material and port housing have caused fractures, migration, infections, and other complications across several product lines.
The claims also argue failure to adequately warn patients and medical providers about the risks associated with each Bard PowerPort catheter device.
Because the reported issues span multiple versions of the port system, several models have been named in the litigation.

Specific Bard PowerPort devices included in the lawsuit may include:
A new lawsuit filed in February 2026 alleges that a defective Bard PowerPort ISP M.R.I. Implantable Port caused severe medical complications for a plaintiff who received the port in March 2023.
The Bard PowerPort MDL has seen a significant increase in claims, with nearly 100 new plaintiffs joining since August 2023.
The Bard PowerPort implant was designed to provide long-term vascular access for patients needing frequent infusions or chemotherapy, but evidence suggests serious flaws in its materials and construction.
The catheter material used in the Bard PowerPort, Chronoflex AL, has been shown to degrade over time, leading to complications such as thrombosis and infections.
When these fragments enter a vein, they can obstruct blood flow, migrate to the heart or lungs, and cause life-threatening embolisms.
Plaintiffs in the Bard PowerPort litigation claim that Bard used an excessive amount of barium sulfate, which made the polymer more brittle and susceptible to stress cracking.

Internal testing and FDA reports indicate that the degraded material can shed particles or harbor bacteria, increasing the risk of infection and inflammation.
Many patients required surgical removal or replacement of their ports due to these failures.
In essence, the issue with Bard PowerPort catheters lies in the combination of flawed material composition and inadequate warning to physicians and patients about its risks.
The Bard PowerPort has been linked to serious health complications, including thrombosis, myocardial infarction symptoms, pulmonary embolism, organ damage, and infections.
Patients have reported a wide range of serious complications and injuries, many of which required emergency medical treatment or corrective surgery.
Complications associated with the Bard PowerPort include catheter fractures, which can lead to severe internal injuries and require additional medical procedures.
These events are often linked to structural failures within the port system, allowing fragments or bacteria to enter the bloodstream and cause cascading harm.
As with other high-risk medical devices, defects in material stability and long-term performance may expose patients to significant vascular and cardiac dangers.
Because of these risks, individuals with a Bard PowerPort implant have experienced injuries that span from localized damage to severe systemic events.
Infections are a significant risk associated with Bard PowerPort devices, as they provide a pathway for bacteria to enter the bloodstream, potentially leading to sepsis.
Patients with Bard PowerPort implants may experience serious complications such as septic infections, cardiac events linked to blood clots, and torn vascular tissue due to the device’s design flaws.

Serious Injuries and Complications Related to the Bard PowerPort Device may include:
If you’ve experienced any of the above injuries or complications, reach out to an experienced PowerPort Lawyer for a free consultation.
TorHoerman Law’s team of attorneys can help you seek justice.
Injuries from implanted port devices can be devastating, and it can be difficult for victims to understand what went wrong and how they can proceed.
There have been several reports of injuries from Bard implantable ports, and lawsuits are currently being filed against the medical device manufacturer.

If you or a loved one were injured by a Bard implantable port catheter device, you may be eligible to file a Bard PowerPort Lawsuit and pursue financial compensation.
Contact our Bard PowerPort Lawyers for a free consultation.
Use the chatbot on this page to find out if you qualify for the Bard PowerPort Lawsuit instantly.
Your Bard PowerPort Lawyers will help you complete the steps necessary to filing a claim, such as gathering evidence and assessing damages.
Your attorney and their legal team will guide you through the legal process and make sure your rights are protected.
Evidence is extremely important in product liability lawsuits, especially ones concerning defective medical devices.
Your Bard PowerPort Injury Lawyer will help you gather and retain evidence relevant to your case, but this is a step you can begin on your own.

Evidence in lawsuits for injuries from Bard PowerPort catheters may include:
Damages are the total losses that you incur as a result of your Bard PowerPort injury.
This can include both economic and non-economic losses that you have incurred as a direct result of a defective Bard PowerPort device.
To calculate total damages that you have incurred, consult with a Bard PowerPort injury attorney from TorHoerman Law today.

Potential Damages in a Bard PowerPort Lawsuit may include:
An experienced lawyer can help calculate and determine the unique damages in your individual case.
Our team of dedicated attorneys, with more than 100 years of combined litigation experience, have helped clients win more than $4 billion in verdicts and negotiated settlements for injuries suffered at no fault of their own.

If you or a loved one were injured by Bard PowerPort devices, you may be eligible to file a Bard PowerPort Lawsuit against the medical device manufacturer.
Contact TorHoerman Law for a free consultation.
You can also use the chatbot on this page to find out if you qualify for a Bard PowerPort Lawsuit instantly.
Our attorneys work on a contingency fee basis – so our clients don’t pay any legal fees unless they are awarded compensation for their injuries & other losses.
Reach out to us if you were injured by a defective device. We’re here to help you.
The Bard PowerPort device has faced significant concerns due to flaws associated with its catheter component.
The FDA has received numerous adverse event reports indicating that the Bard PowerPort has a higher failure rate than other similar products on the market, primarily due to design flaws.
The use of Chronoflex AL, a polyurethane material, has potentially led to structural weaknesses, making the device prone to fractures, migration, and malfunction post-implantation.
Allegations point to manufacturing defects, including improper mixing and an excessive concentration of barium sulfate particles in the catheter body, resulting in irregular surfaces with fissures and cracks on the catheter surface.
The degradation of the catheter’s mechanical properties over time due to the disassociation of barium sulfate particles may compromise the device’s intended durability.
Certain lots of the PowerPort duo M.R.I. Implantable Port were voluntarily recalled in 2022 due to safety concerns.
Bard has previously announced recalls on their implanted port device and IVC filters, but there not an active recall on the Bard PowerPort device for injuries mentioned in lawsuit claims.
No.
There is no Bard PowerPort class action lawsuit.
Instead, the federal cases are consolidated into the Bard PowerPort multidistrict litigation, also known as the Bard PowerPort MDL (MDL No. 3081).
An MDL is different from a class action because each plaintiff keeps an individual claim, maintains control over their case, and must prove their own injuries and damages.
The MDL process simply groups similar port catheter lawsuit claims before one judge to streamline discovery, manage expert evidence, and organize bellwether trials.
In a class action, one or a few representatives stand in for the entire group; in an MDL, every injured person pursues compensation based on the unique facts of their case.
The Bard PowerPort lawsuit is still ongoing, and no global settlement has been reached.
Even so, attorneys reviewing these claims have projected that the average Bard PowerPort lawsuit settlement may fall in the $150,000 to $300,000 range, with some cases potentially exceeding $1 million depending on the severity of the injury and the strength of the evidence.
Cases involving vascular damage directly tied to fracture or migration may be valued in the $175,000 to $350,000 range, while claims involving thrombosis or pulmonary embolism may fall around $100,000 to $250,000.
Infection-related cases are often projected lower, around $30,000 to $100,000, in part because causation can be more difficult to prove.
These figures are estimates only, not guaranteed outcomes, and any recovery will depend on the specific medical record, damages, and how the litigation develops.
Potential defects with the Bard PowerPort device can result in serious complications and injuries.
Lawsuits claim that the catheter port material used in the Bard PowerPort device can break away from the device and cause catheter migration and catheter fracture.
Potential Bard PowerPort complications and injuries include:
Bard Access Systems Inc. manufactures the Bard PowerPort device.
Bard Access Systems Inc was acquired by Becton Dickinson and Company in 2017 for approximately $24 billion.
An implanted port catheter device consists of an injection port and a catheter.
The injection port, placed beneath the skin, serves as an access point for medical procedures.
A specialized needle is inserted through the port’s septum to administer medications, draw blood, or provide fluids.
The catheter, a flexible tube connected to the port, extends into a large vein, enabling direct delivery of treatments into the bloodstream, minimizing discomfort and reducing the need for frequent needle insertions.
The Bard PowerPort devices can withstand higher injection pressure than other implantable port catheter devices, making it a useful option for medications and intravenous fluids that require rapid injection.
You may be eligible to file a Bard PowerPort Lawsuit if:
Contact TorHoerman Law’s Bard PowerPort Injury Lawyers for a free consultation.
You can also use the chatbot on this page to find out if you qualify to file a Bard PowerPort Lawsuit instantly.
The Bard port catheter lawsuit filings claim that Bard’s implantable port systems contained material and design defects that increased the risk of fracture, migration, and infection.
Plaintiffs argue that catheter failure allowed broken fragments or bacteria to enter major veins, leading to serious medical injuries.
These cases further allege that Bard failed to properly test the device and did not warn patients or physicians about known risks.
All federal cases have been consolidated in federal court through multidistrict litigation to manage evidence and pretrial proceedings efficiently.
Allegations include:
A Bard PowerPort is one of several power injectable implantable ports used to provide long-term access to a patient’s vascular system for chemotherapy, IV treatments, IV fluids, blood draws, blood transfusions, antibiotics, and nutritional support.
The device consists of a plastic or metal port with a self-sealing silicone septum connected to a catheter placed under the skin, usually in the chest or arm, and threaded into a large vein near the heart.
Because these injectable implantable ports are designed for repeated port access, they are intended to reduce complications associated with external lines and support patient safety during ongoing treatment for many patients implanted with these devices.
Bard also states that the device can withstand high-pressure contrast injections for CT imaging and provides patients with an identification card and bracelet so clinicians know the port is approved for that use.
When a Bard PowerPort fails, patients may experience severe complications that interfere with normal blood flow and create serious risks inside the vascular system.
Reported problems include resistance during port access, difficulty with blood draws, catheter fracture, infection, internal bleeding, life threatening blood clots, and injuries that may occur if broken catheter components puncture blood vessels or disrupt normal blood flow through the catheter tunnel or nearby veins.
In more serious cases, patients may face port erosion, port pocket site perforation, implanted device laceration, or emergency surgery to remove fractured components, which is one reason patients and providers are often told to report adverse events involving these devices.
These types of allegations have also appeared in lawsuits centralized by the United States Judicial Panel on Multidistrict Litigation, where pretrial issues are handled through the MDL process, including at the case management conference stage.
Owner & Attorney - TorHoerman Law
Here, at TorHoerman Law, we’re committed to helping victims get the justice they deserve.
Since 2009, we have successfully collected over $4 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?
At TorHoerman Law, we believe that if we continue to focus on the people that we represent, and continue to be true to the people that we are – justice will always be served.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
In this case, we obtained a verdict of $495 Million for our client’s child who was diagnosed with Necrotizing Enterocolitis after consuming baby formula manufactured by Abbott Laboratories.
In this case, we were able to successfully recover $20 Million for our client after they suffered a Toxic Tort Injury due to chemical exposure.
In this case, we were able to successfully recover $103.8 Million for our client after they suffered a COX-2 Inhibitors Injury.
In this case, we were able to successfully recover $4 Million for our client after they suffered a Traumatic Brain Injury while at daycare.
In this case, we were able to successfully recover $2.8 Million for our client after they suffered an injury due to a Defective Heart Device.
Here, at TorHoerman Law, we’re committed to helping victims get the justice they deserve.
Since 2009, we have successfully collected over $4 Billion in verdicts and settlements on behalf of injured individuals.
Would you like our help?